NCT01962298View on ClinicalTrials.gov

Recovery of Diaphragmatic Function After Neuromuscular Blockade and Sugammadex

PHASE3CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Diaphragmatic DysfunctionMuscle WeaknessMuscle Fatigue
Interventions
DRUG

sugammadex 2mg/kg

DRUG

neostigmine

DRUG

sugammadex 4mg/kg

DRUG

placebo

DRUG

Single rocuronium dose

DRUG

Repeated rocuronium dose

DRUG

Continuous rocuronium infusion

Trial Locations (1)

2650

Antwerp University Hospital, Edegem

All Listed Sponsors
lead

University Hospital, Antwerp

OTHER

NCT01962298 - Recovery of Diaphragmatic Function After Neuromuscular Blockade and Sugammadex | Biotech Hunter | Biotech Hunter